Semiannual Report — FY2026 H1
What NIPRO CORPORATION reported for the period from 2026-04-01 to 2027-03-31.
Filed 2026-11-16View the original on EDINET
How much it says
40Thin
What moved here
7named for the first time
Its own wording
14terms
Which filing this is
35/ 35newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the current interim consolidated accounting period, net sales increased year on year, while operating profit and ordinary profit declined. The segment classifications were also changed. Nipro Asia Pacific Group Pte. Ltd. was included in the scope of consolidation as a consolidated subsidiary, while Avantec Vascular Corporation was removed from the scope of consolidation following an absorption-type merger.
Komori's summary of this document, not the document's own words.40Thin
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 34 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
61
Detailed
70
Detailed
16
Almost nothing
62
Detailed
0
Almost nothing
68
Detailed
27
Almost nothing
0
Almost nothing
0
Almost nothing
73
Detailed
R&D spend126億円Money spent making new things.
Cash left over-163億円Cash from the business, less what went into equipment.
Spent on equipment320億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.